Iron deficiency anemia (IDA) is a prevailing nutritional inadequacy observed in pregnant women globally. Based on the 2018 national nutrition survey of Pakistan, 41.7% of women between the ages of 15 and 49 suffer from anemia. Anemia is regarded as a risk factor for maternal mortality and associated problems like an elevated likelihood of preterm birth, underweight newborns, and postpartum depression. The objective of this study was to assess the impact of hematogen shots on pregnant women with iron deficiency anemia in the Faisalabad district. Another objective of this study was to formulate iron-enriched shots with the aim of enhancing the iron levels in pregnant women suffering from iron deficiency anemia (IDA). Iron-enriched shots were prepared by combining soybean, chickpea, spinach, and red kidney beans in various combinations. This study involved 9 pregnant women who were diagnosed with iron deficiency anemia (IDA) and who were observed for a period of 30 days. Five treatments were chosen, namely T_o (control group), T_I (red kidney beans + soybean), T₂ (red kidney beans + chickpea), and T₃ (spinach + soybean). Three groups of pregnant women, each consisting of three individuals, were assigned to receive T₄ treatment with a combination of spinach and chickpea. An efficacy trial was chosen as an experimental design in this study. Participants were administered hematogen shots twice daily. Hemoglobin levels were measured at the beginning of the intervention and again after 30 days. These shots underwent compositional analysis to determine their proximal, mineral qualities. The results were subjected to descriptive statistics and ANOVA for analysis to determine their level of significance, which was p < 0.05. This study determined that T₄ is more efficacious than other treatments in increasing hemoglobin levels, making it a viable choice for meeting the daily needs of pregnant women with iron deficiency anemia (IDA).